Kardigan, Inc. (KARD) vs Omada Health (OMDA)
A side-by-side comparison of Kardigan, Inc. and Omada Health across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KARD
Kardigan, Inc.
$14.17HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
OMDA
Omada Health
$20.67HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — KARD vs OMDA
growth of $100 · dividends reinvested · last 1yKARD -30.7% (-30.7%/yr)OMDA +18.8% (+18.8%/yr)OMDA compounded faster over this window
KARD OMDA
KARD vs OMDA: by the numbers
- •KARD is the larger company ($1.27B vs $1.23B market cap).
- •OMDA is profitable (1.39% net margin) while KARD runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | KARD | OMDA |
|---|---|---|
| P/E ratio | N/A | 328.16 |
| P/S ratio | N/A | 3.97 |
| P/B ratio | 2.06 | 4.86 |
| EV / EBITDA | N/A | 145.17 |
| FCF yield | N/A | 1.63% |
Profitability
| Metric | KARD | OMDA |
|---|---|---|
| Gross margin | 0.00% | 68.19% |
| Operating margin | 0.00% | -0.15% |
| Net margin | 0.00% | 1.39% |
| ROE | N/A | 1.70% |
| ROIC | -57.11% | -0.18% |
Frequently asked
- Is KARD or OMDA more profitable?
- OMDA runs the higher net margin — KARD at 0.00% versus OMDA at 1.39%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.